본문 바로가기

Genotype-phenotype correlations in valosin-containing protein disease: a retrospective muticentre study

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1Scopus Q1
피인용
Web of Science 41Scopus 41
FWCI (Scopus)
4.05
JCR IF
JCR 2021 13.654
ISSN
0022-3050

저자

  1. Schiava, Marianela제1저자Newcastle Univ, John Walton Muscular Dystrophy Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England
  2. Ikenaga, ChisekoJohns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA
  3. Villar-Quiles, Rocio NurSorbonne Univ, Hop Pitie Salpetriere, AP HP, Ctr Reference Malad Neuromusculaires,Inst Myol, Paris, France
  4. Caballero-Avila, MartaDept Neurol, Neuromuscular Disorders Unit, Hosp Santa Creu & St Pau, Barcelona, Spain
  5. Topf, AnaNewcastle Univ, Newcastle Univ & Newcastle Hosp NHS Fdn Trusts, Newcastle Upon Tyne, Tyne & Wear, England
  6. Nishino, IchizoNatl Ctr Neurol & Psychiat NCNP, Dept Neuromuscular Res, Natl Inst Neurosci, Tokyo, Japan
  7. Kimonis, VirginiaUniv Calif Irvine, Irvine Med Ctr, Dept Pediat, Div Genet & Genom Med,Childrens Hosp Orange Cty, Orange, CA USA
  8. Udd, BjarneTampere Univ Hosp, Tampere Neuromuscular Ctr, Tampere, Finland
  9. Schoser, BenediktLudwig Maximilian Univ Clin, Dept Neurol, Friedrich Baur Inst, Munich, Germany
  10. Zanoteli, EdmarUniv Sao Paulo FMUSP, Sch Med, Dept Neurol, Sao Paulo, Brazil
  11. Sgobbi Souza, Paulo VictorUniv Fed Sao Paulo UNIFESP, Disciplina Neurol, Sao Paulo, Brazil
  12. Tasca, GiorgioFdn Policlin Univ A Gemelli, Unita Operat Complessa Neurol, IRCCS, Rome, Italy
  13. Lloyd, ThomasJohns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA
  14. Lopez-de Munain, AdolfoBiodonostia Osakidetza Basque Hlth Serv, Biodonostia Neurosci Area Grp Neuromuscular Dis, San Sebastian, Spain
  15. Paradas, CarmenHosp Univ Virgen del Rocio, Neurol Dept, Neuromuscular Disorders Unit, Seville, Spain
  16. Pegoraro, ElenaUniv Padua, Dept Neurosci, Padua, Italy
  17. Nadaj-Pakleza, AleksandraUniv Hosp Strasbourg, Ctr Reference Maldies Neuromusculaires Nord Est I, Dept Neurol, Strasbourg, France
  18. De Bleecker, JanGhent Univ Hosp, Dept Neurol, Ghent, Belgium
  19. Badrising, UmeshLeiden Univ Med Ctr, Dept Neurol, Leiden, Netherlands
  20. Alonso-Jimenez, AliciaUniv Antwerp, Antwerp Univ Hosp, Neuromuscular Reference Ctr, Inst Born Bunge,Dept Neurol, Antwerp, Belgium
  21. Kostera-Pruszczyk, AnnaMed Univ Warsaw, Dept Neurol, European Reference Network ERN NMD, Warsaw, Poland
  22. Miralles, FrancescHosp Univ Son Espases, Dept Neurol, Unitat Patol Neuromuscular & Gabinet Delectrodiag, Palma De Mallorca, Spain
  23. 신진홍Pusan Natl Univ, Lab Mol Neurol, Yangsan Hosp, Yangsan, South Korea
  24. Bevilacqua, Jorge AlfredoHosp Clin Univ Chile, Dept Neurol & Neurocirug, Unidad Neuromuscular, Santiago, Chile
  25. Olive, MontseCtr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain
  26. Vorgerd, MatthiasRuhr Univ, Heimer Inst Muscle Res, Klinikum Bergmannsheil, Bochum, Germany
  27. Kley, RudiSt Marien Hosp Borken, Dept Neurol & Clin Neurophysiol, Borken, Germany
  28. Brady, StefenJohn Radcliffe Hosp, Neurol Dept, Oxford, England
  29. Williams, TimothyRoyal Victoria Infirm, Newcastle Motor Neurone Dis Care Ctr, Newcastle, NSW, Australia
  30. Dominguez-Gonzalez, CristinaCtr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain
저자 61명 모두 보기

초록

Background Valosin-containing protein (VCP) disease, caused by mutations in the VCP gene, results in myopathy, Paget's disease of bone (PBD) and frontotemporal dementia (FTD). Natural history and genotype-phenotype correlation data are limited. This study characterises patients with mutations in VCP gene and investigates genotype-phenotype correlations. Methods Descriptive retrospective international study collecting clinical and genetic data of patients with mutations in the VCP gene. Results Two hundred and fifty-five patients (70.0% males) were included in the study. Mean age was 56.8 +/- 9.6 years and mean age of onset 45.6 +/- 9.3 years. Mean diagnostic delay was 7.7 +/- 6 years. Symmetric lower limb weakness was reported in 50% at onset progressing to generalised muscle weakness. Other common symptoms were ventilatory insufficiency 40.3%, PDB 28.2%, dysautonomia 21.4% and FTD 14.3%. Fifty-seven genetic variants were identified, 18 of these no previously reported. c.464G>A (p.Arg155His) was the most frequent variant, identified in the 28%. Full time wheelchair users accounted for 19.1% with a median time from disease onset to been wheelchair user of 8.5 years. Variant c.463C>T (p.Arg155Cys) showed an earlier onset (37.8 +/- 7.6 year) and a higher frequency of axial and upper limb weakness, scapular winging and cognitive impairment. Forced vital capacity (FVC) below 50% was as risk factor for being full-time wheelchair user, while FVC Conclusion This study expands the knowledge on the phenotypic presentation, natural history, genotype-phenotype correlations and risk factors for disease progression of VCP disease and is useful to improve the care provided to patient with this complex disease.

키워드

MUSCLE DISEASEGENETICSMYOPATHYINCL BODY MYOSITISFRONTOTEMPORAL DEMENTIAINCLUSION-BODY MYOPATHYPAGET-DISEASEMUSCULAR-DYSTROPHYVCP MUTATIONMULTISYSTEM PROTEINOPATHYBONEVARIABILITYFAMILIESSPECTRUM

식별자

Scopus EID
2-s2.0-85135725421
WoS UID
000832647100001